Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation.

about

Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation.

Item

http://www.wikidata.org/entity/Q46781197

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Liposomes containing glucosyl ...... bling nanocarrier formulation.

@en

Liposomes containing glucosyl ...... bling nanocarrier formulation.

@nl

type

Item

label

Liposomes containing glucosyl ...... bling nanocarrier formulation.

@en

Liposomes containing glucosyl ...... bling nanocarrier formulation.

@nl

prefLabel

Liposomes containing glucosyl ...... bling nanocarrier formulation.

@en

Liposomes containing glucosyl ...... bling nanocarrier formulation.

@nl

P1476

Liposomes containing glucosyl ...... bling nanocarrier formulation.

@en

P2093

Carl R Alving

http://www.w3.org/2001/XMLSchema#string

Kristina K Peachman

http://www.w3.org/2001/XMLSchema#string

Ludmila Asher

http://www.w3.org/2001/XMLSchema#string

Mangala Rao

http://www.w3.org/2001/XMLSchema#string

Venigalla B Rao

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and location of gene product 8 in the bacteriophage T4 baseplate

Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension

The N-terminal ATPase site in the large terminase protein gp17 is critically required for DNA packaging in bacteriophage T4.

Multicomponent anthrax toxin display and delivery using bacteriophage T4.

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins.

Highly effective generic adjuvant systems for orphan or poverty-related vaccines

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives.

Design and selection of vaccine adjuvants: animal models and human trials.

Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.

P304

279-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08982104.2011.559646

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21401373

http://www.w3.org/2001/XMLSchema#string

P921

bacteriophage

nanocarrier

self-assembly